Levofloxacin Lactate Injection
Function and Efficacy
This product is the levorotatory form of ofloxacin, and its antibacterial activity is about 2 times that of ofloxacin. Its main mechanism of action is to inhibit bacterial DNA gyrase activity and inhibit bacterial DNA replication. It has the characteristics of broad antibacterial spectrum and strong antibacterial effect. It has strong antibacterial activity against most Enterobacteriaceae, such as Klebsiella pneumoniae, Proteus, Salmonella typhi, Shigella, influenza bacillus, some Escherichia coli, Pseudomonas aeruginosa, gonococci, etc. It also has good antibacterial effect against some Staphylococci, Streptococcus pneumoniae, Chlamydia, etc.
Ingredients
Main ingredients and chemical name of this product: The main ingredient of this product is levofloxacin lactate, and its chemical name is: (S)-(-)-9-fluoro-2-,3-dihydro-3-methyl-10(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de][1,4]-benzoxazine-6-carboxylic acid lactate hemihydrate. [Molecular formula] C18H20FN3O4C3H6O31/2H2O [Molecular weight] 460.41
| Name | Description | Content | CAS NO. | Manufacturer |
|---|---|---|---|---|
| LEVOFLOXACIN LACTATEIngredients |
This product is the levorotatory form of ofloxacin, and its antibacterial activity is about 2 times that of ofloxacin. Its main mechanism of action is to inhibit bacterial DNA gyrase activity and inhibit bacterial DNA replication. It has the characteristics of broad antibacterial spectrum and strong antibacterial effect. It has strong antibacterial activity against most Enterobacteriaceae (such as Klebsiella pneumoniae, Proteus, Salmonella typhi, Shigella, influenza bacillus, some Escherichia coli, Pseudomonas aeruginosa, gonococci, etc.); it also has good antibacterial effect against some Staphylococci, Streptococcus pneumoniae, Chlamydia, etc. More |
294662-18-3 | 11 |
Indication
It is suitable for moderate to severe respiratory system, urinary system, digestive system and skin and soft tissue infections caused by sensitive strains of Gram-negative bacteria and Gram-positive bacteria, sepsis, typhoid and paratyphoid dysentery, and urethritis and cervicitis caused by gonococci and Chlamydia trachomatis.
Usage and Dosage
Intravenous drip: Adults: 0.1-0.2g at a time, twice a day, or as directed by a doctor.
Adverse Reactions
Poor appetite, nausea, vomiting, diarrhea, insomnia, dizziness, headache, rash, elevated serum alanine aminotransferase and local irritation symptoms after injection may occur occasionally, but they are generally tolerated and disappear after the treatment.
Precautions
1. It is contraindicated for those who are allergic to quinolones and epileptic patients; 2. It is contraindicated for pregnant and lactating women; 3. It is contraindicated for patients under 16 years old.
Special Population Medication
Precautions for children: Not for use in patients under 16 years of age. Precautions for pregnancy and lactation: Not for use in pregnant or lactating women.
Drug Interactions
Not yet clear.
Storage
Keep away from light and store in a sealed container.
Packaging Specification
2ml:0.1g (calculated according to C18H20FN3O4)
Manufacturer
Suzhou Tianma PHARMA Group Tianji BIO-PHARMACEUTICAL Co., Ltd.
-
Founded in:
2000-06-21 -
Address:
No. 199, Huayuan East Road, Mudu Town, Wuzhong District, Suzhou City -
Tax NO.:
91320506720538941C -
Registered Funds:
220 million yuan -
Website:
-
Email: